Monoclonal Antibodies Administered Following Transplant

 Monoclonal Antibodies Administered Following Transplant

 

Monoclonal antibodies given following transplanta-t ion are u sed to t re at allograft rejection. Administration of these agents is mainly reserved for severe allograft rejection in which the immunolo-gic insult must be controlled quickly. Under normal homeostatic conditions the humoral immune system provides immediate control of infectious pathogens through secretion of antibodies. Cell mediated im-munity, in addition to fighting infections, provides surveillance against the production of mutant cells capable of oncogenesis. Interruption of either of these immune systems through the use of monoclonal antibodies places these patients at significant risk for infection and malignancy. Careful post administration assessment of infection and post-transplant malig-nancy is commonplace.

Comments

Post a Comment

Popular posts from this blog

Adenoviral Vectors - Viral Vectors for Gene Transfer

Image
  Viral Vectors for Gene Transfer   Viruses, natural parasites that efficiently enter cellular targets and hijack cellular machinery for propagation, are currently the most effective vectors for gene therapy. Approximately 70% of all gene therapy clinical trials employ viral vectors (Table 4). Many viruses with divergent properties have been devel-oped for gene transfer. Retroviruses, adenoviruses and adeno-associated viruses (AAVs) are the most extensively studied to date. Characteristics of each are summarized in Table 5.   Adenoviral Vectors Biology   Adenoviruses are non-enveloped, lytic, DNA viruses with a linear double-stranded genome and icosahedral symmetry. Since the isolation of the first human adenovirus in 1953 from tonsils and adenoid tissue (Rowe, 1953), 50 additional serotypes have been identified and grouped into six species (A–F) based on genome size, composition and homology, hemag-glutinating properties and oncogenicity in rodents. Because the subg...
Read more

Direct Binding to Non-Nucleic Acids

Image
  DIRECT BINDING TO NON-NUCLEIC ACIDS The ability of nucleic acids to fold into complex three-dimensional structures through regions of (partial) complementarity allows them to bind to virtually any molecule with nano- to picomolar affinity (Proske et al., 2005). This high affinity is supported by data on their extreme specificity. A nucleic acid sequence specifically binding theophylline has a million times higher affinity for theophylline than caffeine, mole-cules which differ by only one methyl group.   Aptamers/Riboswitches   Aptamers and riboswitches are single-stranded ONs of either DNA or RNA, generally about 60 nucleotides long, which fold into well-defined three-dimensional structures. They bind to their target molecule by complementary shape interactions accompanied by charge and hydrophobic interactions and hydrogen bridges. The target can be small molecules or macromolecules. Aptamers are isolated artificially, whereas riboswitches occur naturally (Tucker and ...
Read more

Uptake - Immunological Principles of Vaccines

  Uptake   Every immune reaction against a pathogen starts with its uptake by specialized phagocytic cells in the infected tissue. These cells carry receptors on their surface; pattern-recognition receptors (PRRs) that recognize common features of pathogens called pathogen associated molecular patterns (PAMPs). Binding of PAMPs to these PRRs results in phagocy-tosis of the pathogens. Examples of PRRs are toll-like receptors (TLRs), scavenger receptors and C-type lectins (Table 2). TLRs consist of a family of receptors, with each member recognizing different patterns on the surface of pathogens ( Akira et al., 2006). TLRs canbe found on many cells including macrophages and dendritic cells (DCs). DCs can also engulf materials from their extracellular environment by a receptor independent process called micropinocytosis.
Read more